EPISODE · May 18, 2026 · 7 MIN
Bioretec Q1'26: The beginning of the year offered positive signs
from Inderes · host Inderes
Bioretec's Q1 earnings positively surprised in terms of revenue and profit, particularly due to growth in the US and European markets. Bioretec's CEO, Sarah Hubar-Fisher, tells more about the first quarter in an interview with analyst Antti Siltanen.Topics:00:00 Introduction00:15 Positive signs from the beginning of the year01:41 Drivers behind the numbers02:39 RemeOs sales03:08 Orders affecting the comparison period04:00 Taking RemeOs to China04:37 Expanding the distributor network05:35 Recruitment situation06:30 Operational priorities for the rest of the year
Embed this episode
Ready to play
Bioretec Q1'26: The beginning of the year offered positive signs
No transcript for this episode yet
Similar Episodes
No similar episodes found.